×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Xerosis Market

ID: MRFR/Pharma/18551-HCR
100 Pages
Rahul Gotadki
October 2025

US Xerosis Market Research Report By Treatment (emollients, moisturizer, humidifier, oils, others), By Causes (eczema, psoriasis, diabetes, hypothyroidism, aging, others) and By End Users (hospitals, dermatology clinics, home care) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Xerosis Market Infographic
×
US Xerosis Market Infographic Full View
Purchase Options

US Xerosis Market Summary

As per Market Research Future analysis, the US xerosis market Size was estimated at 714.0 USD Million in 2024. The US xerosis market is projected to grow from 742.63 USD Million in 2025 to 1100.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.0% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The US xerosis market is experiencing a robust growth trajectory driven by evolving consumer preferences and increasing awareness of skin health.

  • The demand for moisturizers is rising as consumers seek effective solutions for xerosis.
  • There is a notable shift towards natural ingredients in skincare formulations, reflecting changing consumer values.
  • Technological advancements in product formulations are enhancing the efficacy of xerosis treatments.
  • The increasing prevalence of xerosis and heightened awareness of skin health are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 714.0 (USD Million)
2035 Market Size 1100.0 (USD Million)
CAGR (2025 - 2035) 4.01%

Major Players

Johnson & Johnson (US), Bayer AG (DE), Galderma S.A. (CH), Eucerin (DE), CeraVe (US), Neutrogena (US), Aveeno (US), La Roche-Posay (FR), Avene (FR)

US Xerosis Market Trends

The xerosis market is currently experiencing notable growth, driven by an increasing prevalence of dry skin conditions among various demographics. Factors such as environmental changes, lifestyle choices, and an aging population contribute to the rising demand for effective treatments and preventive measures. As awareness of skin health continues to expand, consumers are seeking products that not only alleviate symptoms but also promote overall skin hydration and wellness. This trend is further supported by advancements in dermatological research, leading to the development of innovative formulations that cater to diverse skin types and conditions. In addition, the xerosis market is witnessing a shift towards natural and organic products, as consumers become more conscious of the ingredients in their skincare routines. This inclination towards clean beauty is prompting manufacturers to reformulate existing products and introduce new lines that emphasize sustainability and safety. The regulatory landscape is also evolving, with increased scrutiny on product claims and ingredient transparency, which may influence consumer purchasing decisions. Overall, the xerosis market appears poised for continued expansion, reflecting broader trends in health and wellness, as well as a growing emphasis on personalized skincare solutions.

Rising Demand for Moisturizers

There is a noticeable increase in the demand for moisturizers specifically designed for xerosis. Consumers are actively seeking products that provide long-lasting hydration and relief from dry skin symptoms. This trend is likely influenced by heightened awareness of skin health and the importance of maintaining skin moisture.

Shift Towards Natural Ingredients

A significant trend within the xerosis market is the growing preference for products containing natural and organic ingredients. Consumers are becoming more discerning about the formulations they choose, often favoring those that are free from synthetic additives. This shift may reflect a broader movement towards clean beauty and sustainability.

Technological Advancements in Formulations

Innovations in formulation technology are shaping the xerosis market. Manufacturers are increasingly investing in research and development to create advanced products that effectively address dry skin issues. These advancements may include the incorporation of new active ingredients and delivery systems that enhance product efficacy.

US Xerosis Market Drivers

Awareness of Skin Health

There is a notable increase in consumer awareness regarding skin health, which significantly impacts the xerosis market. Educational campaigns and health initiatives have led to a better understanding of skin conditions, including xerosis. As individuals become more informed about the importance of skin hydration and the potential complications of untreated dry skin, they are more inclined to seek out effective products. Market data suggests that the demand for moisturizers and hydrating treatments has surged by approximately 25% over the past few years. This heightened awareness not only drives sales but also encourages manufacturers to innovate and improve their product offerings, thereby enhancing the overall competitiveness of the xerosis market.

Growth of E-commerce Platforms

The expansion of e-commerce platforms has transformed the way consumers access products in the xerosis market. Online shopping provides convenience and a wider selection of products, allowing consumers to easily compare options and read reviews. Recent statistics indicate that online sales of skincare products have increased by over 40% in the past year alone. This shift towards digital purchasing is particularly beneficial for niche products targeting xerosis, as consumers can find specialized solutions that may not be available in traditional retail settings. Consequently, the growth of e-commerce is likely to play a crucial role in driving the overall sales and visibility of products within the xerosis market.

Increasing Prevalence of Xerosis

The rising incidence of xerosis in the US population is a primary driver for the xerosis market. Factors such as aging, environmental conditions, and lifestyle choices contribute to this trend. According to recent data, approximately 30% of adults in the US experience some form of dry skin, particularly during winter months. This growing prevalence necessitates a wider range of treatment options, thereby expanding the market. The xerosis market is likely to see increased demand for specialized products, including moisturizers and topical treatments, as consumers seek effective solutions to manage their skin condition. Furthermore, the aging population, which is projected to reach 73 million by 2030, will likely exacerbate the demand for xerosis-related products, indicating a robust growth trajectory for the industry.

Rising Interest in Preventive Skincare

The trend towards preventive skincare is gaining traction among consumers, which is a significant driver for the xerosis market. Individuals are increasingly adopting proactive measures to maintain skin health, rather than solely addressing issues as they arise. This shift in mindset has led to a growing demand for moisturizers and hydrating products designed for daily use. Market analysis indicates that preventive skincare products have seen a growth rate of approximately 20% in recent years. As consumers prioritize long-term skin health, the xerosis market is likely to experience sustained growth, with an emphasis on products that promote hydration and skin barrier function.

Regulatory Support for Dermatological Products

Regulatory bodies in the US are increasingly supportive of dermatological products, which positively influences the xerosis market. The Food and Drug Administration (FDA) has streamlined approval processes for certain topical treatments, encouraging innovation and the introduction of new products. This regulatory environment fosters competition among manufacturers, leading to a broader range of effective solutions for consumers suffering from xerosis. Additionally, the approval of new ingredients and formulations can enhance product efficacy, further driving consumer interest. As a result, the xerosis market is likely to benefit from a more dynamic product landscape, with an increasing number of options available to address various degrees of skin dryness.

Market Segment Insights

Xerosis Market Treatment Insights

The Treatment segment of the US Xerosis Market is a critical area driven by the prevalence of dry skin conditions in the population, with millions of Americans experiencing xerosis annually. With the overall market for Xerosis expected to reach 1.65 billion USD by 2024, the Treatment segment plays a significant role in addressing the skin hydration needs of these individuals.

The US Xerosis Market revenue reflects a variety of treatment options aimed at alleviating symptoms and improving skin health. Within this segment, products such as emollients and moisturizers are essential, as they work to create a protective barrier on the skin, locking in moisture and providing relief from dryness. The growing consumer awareness about skincare and increasing preference for natural ingredients are propelling the demand for moisturizers significantly in the US Xerosis Market industry.

Humidifiers also become crucial, especially in arid climates or during winter seasons, where dry air can exacerbate the condition of the skin, thereby enhancing the treatment landscape. Oils, categorized under the Treatment segment, are increasingly recognized for their hydrating properties and ability to nourish and soothe the skin, appealing particularly to consumers seeking natural and organic solutions.

Furthermore, the diverse range of options available within the Treatment segment allows healthcare providers and consumers to select tailored solutions based on individual skin needs. The growth of digital health and telemedicine services has been instrumental in improving access to dermatological care, encouraging consumers to seek professional advice on appropriate treatments. This has resulted in an uptick in the use of combination therapies for xerosis, maximizing treatment effectiveness while addressing various sub-types of dryness.

The penetration of e-commerce platforms has also enabled broader reach, making these Treatment options easily accessible even in remote areas. Increasingly, the US Xerosis Market segmentation is expected to grow, with treatment solutions designed to improve quality of life for individuals dealing with this chronic condition, showcasing a steady evolution in response to consumer needs and trends. In essence, the Treatment segment is pivotal in shaping the landscape of the US Xerosis Market, emphasizing the importance of proper skin hydration and care, ultimately improving the overall wellbeing of those affected by xerosis.

Xerosis Market Causes Insights

The US Xerosis Market is significantly influenced by various causes, which encompass a range of skin conditions and health issues. Among these, eczema and psoriasis are notably prevalent, often leading to chronic dry skin conditions, thus contributing significantly to the Xerosis landscape.

The aging population also plays a critical role, as skin naturally loses moisture and elasticity over time, making elderly individuals more susceptible to Xerosis. Furthermore, underlying health conditions such as diabetes and hypothyroidism exacerbate skin dryness, revealing a complex interplay between systemic health and dermatological symptoms.

In recent years, increased awareness and diagnosis of these skin conditions have driven market dynamics, leading to a surge in demand for specialized products and treatments aimed at alleviating dry skin symptoms. The emphasis on Research and Development in pharmaceuticals and dermatological products is also notable, as innovative therapies offer new solutions for patients. Overall, the addressing of these diverse causes within the US Xerosis Market is vital for understanding the broader market dynamics and consumer needs.

Xerosis Market End Users Insights

The US Xerosis Market revenue reflects a growing landscape focused on various end users, including hospitals, dermatology clinics, and home care settings. Each of these entities plays a crucial role in addressing the challenges posed by xerosis, significantly impacting patient care and treatment outcomes.

Hospitals are key providers of acute medical care, often equipped with advanced technology and professionals who specialize in skin conditions, thus addressing severe cases of xerosis effectively. Dermatology clinics, on the other hand, provide specialized services tailored to skin health, emphasizing preventive care and chronic management, which is essential for maintaining skin integrity and patient comfort.

Home care settings have gained prominence as they offer patients convenience and personalized care, enabling them to manage their condition in a familiar environment. The demand for effective treatments in these settings is continually driven by an increasing awareness of skin health and expanding aging populations in the United States. Overall, the combination of these end users reflects significant opportunities for growth and advancements in managing xerosis conditions across various demographics.

Get more detailed insights about US Xerosis Market

Key Players and Competitive Insights

The xerosis market exhibits a dynamic competitive landscape characterized by a blend of innovation, strategic partnerships, and a focus on consumer-centric solutions. Key players such as Johnson & Johnson (US), Galderma S.A. (CH), and CeraVe (US) are actively shaping the market through their distinct operational strategies. Johnson & Johnson (US) emphasizes innovation in product formulations, particularly in developing advanced moisturizers that cater to diverse skin types. Galderma S.A. (CH) focuses on dermatological expertise, leveraging its strong research capabilities to introduce targeted treatments for xerosis. Meanwhile, CeraVe (US) has carved a niche by promoting its dermatologist-developed products, which resonate well with health-conscious consumers. Collectively, these strategies foster a competitive environment that prioritizes quality and efficacy, thereby driving market growth.

In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain efficiency and reduce costs. This approach not only streamlines operations but also allows for quicker response times to market demands. The competitive structure of the xerosis market appears moderately fragmented, with several players vying for market share. However, the influence of major companies remains substantial, as they set benchmarks for product quality and innovation that smaller firms strive to meet.

In October 2025, Johnson & Johnson (US) announced the launch of a new line of hydrating creams specifically formulated for sensitive skin. This strategic move is likely to enhance their market presence by addressing a growing consumer demand for specialized skincare solutions. The introduction of these products aligns with the company's commitment to innovation and could potentially capture a significant share of the sensitive skin segment within the xerosis market.

In September 2025, Galderma S.A. (CH) expanded its product portfolio by acquiring a niche brand known for its natural ingredients aimed at treating dry skin conditions. This acquisition not only diversifies Galderma's offerings but also strengthens its position in the growing market for natural and organic skincare products. The strategic importance of this move lies in its potential to attract environmentally conscious consumers, thereby enhancing brand loyalty and market penetration.

In August 2025, CeraVe (US) launched a digital campaign aimed at educating consumers about the importance of moisturizing for xerosis management. This initiative reflects a broader trend towards digital transformation in the skincare industry, where companies leverage online platforms to engage with consumers directly. By positioning itself as a thought leader in skincare education, CeraVe is likely to enhance its brand reputation and foster deeper connections with its customer base.

As of November 2025, the xerosis market is increasingly defined by trends such as digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances among companies are becoming more prevalent, facilitating knowledge sharing and resource optimization. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of delivering high-quality, effective solutions that meet the evolving needs of consumers.

Key Companies in the US Xerosis Market include

Industry Developments

The US Xerosis Market has seen notable recent developments and growth dynamics, particularly with companies such as Novartis, Eucerin, GlaxoSmithKline, and Eli Lilly making headlines. Procter and Gamble and Aveeno announced new product launches targeting xerosis, while CeraVe, Dermavant Sciences, and Humboldt Therapeutics continued to expand their therapeutic offerings.

In a significant merger, Allergan finalized a strategic acquisition of a skin care line in June 2023, reflecting consolidation trends in the market. Meanwhile, Amgen and Johnson and Johnson reported advancements in their xerosis-related treatments, contributing to an increasing market valuation. The most recent data indicates a surge in the demand for moisturizers and topical treatments, indicating a sustained interest in xerosis solutions.

Additionally, regulatory changes in August 2023 have improved the approval processes for new dermatological treatments, benefiting companies like Bayer and Mylan. Over the past couple of years, the market has evolved significantly as companies invest in Research and Development to innovate solutions for xerosis, indicating a vibrant and competitive landscape focused on improving patient care in the US.

Future Outlook

US Xerosis Market Future Outlook

The Xerosis Market is projected to grow at 4.01% CAGR from 2024 to 2035, driven by increasing awareness, innovative treatments, and rising prevalence of skin conditions.

New opportunities lie in:

  • Development of targeted topical formulations for specific xerosis types.
  • Expansion of telehealth services for remote patient consultations.
  • Investment in AI-driven diagnostic tools for early xerosis detection.

By 2035, the xerosis market is expected to achieve substantial growth and innovation.

Market Segmentation

US Xerosis Market End User Outlook

  • Hospitals
  • Clinics
  • Home Care
  • Pharmacies

US Xerosis Market Severity Level Outlook

  • Mild
  • Moderate
  • Severe
  • Very Severe

US Xerosis Market Treatment Type Outlook

  • Topical Treatments
  • Oral Medications
  • Advanced Therapies
  • Home Remedies

US Xerosis Market Formulation Type Outlook

  • Creams
  • Lotions
  • Ointments
  • Gels

Report Scope

MARKET SIZE 2024 714.0(USD Million)
MARKET SIZE 2025 742.63(USD Million)
MARKET SIZE 2035 1100.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.01% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Johnson & Johnson (US), Bayer AG (DE), Galderma S.A. (CH), Eucerin (DE), CeraVe (US), Neutrogena (US), Aveeno (US), La Roche-Posay (FR), Avene (FR)
Segments Covered Severity Level, Treatment Type, End User, Formulation Type
Key Market Opportunities Emerging natural ingredients in skincare formulations address increasing consumer demand for xerosis treatment.
Key Market Dynamics Rising consumer awareness drives demand for innovative xerosis treatments amid evolving regulatory standards.
Countries Covered US
Leave a Comment

FAQs

What is the expected market size of the US Xerosis Market in 2024?

The US Xerosis Market is expected to be valued at 1.65 billion USD in 2024.

What is the projected market size of the US Xerosis Market by 2035?

By 2035, the US Xerosis Market is projected to reach a value of 3.5 billion USD.

What is the expected CAGR for the US Xerosis Market from 2025 to 2035?

The expected CAGR for the US Xerosis Market from 2025 to 2035 is 7.075%.

Who are the major players in the US Xerosis Market?

Key players in the US Xerosis Market include Novartis, Eucerin, GlaxoSmithKline, and Eli Lilly among others.

What will be the market value for emollients in the US Xerosis Market by 2035?

The market value for emollients in the US Xerosis Market is anticipated to be 1.1 billion USD by 2035.

How much is the moisturizer segment expected to grow by 2035?

The moisturizer segment is expected to grow to 0.85 billion USD by 2035.

What is the projected market size for humidifiers in the US Xerosis Market in 2035?

The projected market size for humidifiers in the US Xerosis Market is estimated to be 0.7 billion USD by 2035.

How much is the oils segment expected to be valued at in 2035 within the US Xerosis Market?

The oils segment is expected to be valued at 0.45 billion USD in 2035.

What is the anticipated market size for 'others' treatment segment by 2035?

The 'others' treatment segment is anticipated to reach a market size of 0.3 billion USD by 2035.

What are the emerging trends driving growth in the US Xerosis Market?

Emerging trends such as increased awareness about skin health and the rising availability of advanced treatment options are driving growth.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions